News on CML - Archives 2013-2012 - Chronic myeloid leukemia

                  See News on CML (after 2020)                  
                                 See Archives ( 2019-2018)
                  See Archives ( 2017-2016)
                  See Archives ( 2015-2014)
                  See Archives ( 2013-2012)
                                 See Archives before 2012
                            

BioLineRX Ltd. : BioLineRx Highlights Initial Phase 2 Results of Acute Myeloid Leukemia Treatment
December 30, 2013, 4-traders.com
​
Remembering Dr. John Goldman
December 27, 2013, ICMLf

ASH Report #2: First-line trial updates,  STOP trials, early switching, comorbidities, side  effects
December 27, 2013, CML  advocates  network

Top Clinical Cancer Advances: ASCO 2013  Report. Two new drugs were approved for chronic myeloid leukemia (Omacetaxine mepesuccinate (Synribo), Ponatinib (Iclusig) )
December 26, 2013, Medscape

Professor John M Goldman Past away this  afternoon
December 24, 2013, cmlsupport

Dr. Shapiro Discusses Bosutinib in CML   VIDEO
December 23, 2013, OncLIve

The Changing CML Treatment Landscape (Dr. Jessica Altman)          VIDEO
December 20, 2013, Patient  Power

Off and On Again Story of Ponatinib in  CML – by Michael Deininger, reporting from ASH 2013 
December 20, 2013, Medscape
 
After Brief  Halt, FDA Allows Sales of Drug for Cancer to  Resume
December 20, 2013, New York  Times

Memorial Sloan-Kettering Mourns the  Death of Cancer Research Pioneer Janet  Rowley
December 20, 2013, Memorial Sloan-Kettering Cancer  Center

OncoBlog:  Driving the CAR to a Cancer Cure?
December 19, 2013, MedPage  Today

Janet Rowley dies at 88; scientist pinpointed genetic cause of  leukemia
December 19, 2013,  Los Angeles  Times

Janet Rowley,  1925-2013: U. of C. scientist made breakthrough cancer  discoveries
December 18, 2013, Chicago Tribune  News

How Gleevec Changed the Game for  Novartis
December 18, 2013, The Motley  fool
 
Ariad Pharmaceuticals - Positive News  From Regulators
December 18, 2013, Seeking  Alpha

Bosutinib safety and management of  toxicity in leukemia patients with resistance or intolerance to imatinib and
other tyrosine kinase inhibitors
December 17, 2013, Journal  Blood

Preclinical data shows BGB324 as  potential treatment option for Chronic Myeloid  Leukemia
December 17, 2013, News medical

Study identifies reasons for CML  non-adherence
December 16, 2013,  ecancernews
​
Cancer as a metabolic disease: implications for novel therapeutics
December 16, 2013, NCBI

Persistent  patient: Man earns diploma after fight with  leukemia
December 15, 2013, Joplin  Globe

Patient Advocate Point of View at  American Society of Hematology (ASH)
December 13, 2013,  Md Anderson Cancer  Center

Dasatinib+letrozole improves survival  for women with hormone receptor-positive, HER2-negative metastatic breast cancer
December 13, 2013, News  Medical

Drug Combo Delayed Progression in Some  Metastatic Breast Cancer Patients
December 13, 2013, Cancer  Network

Drug May Help Slow Advanced  Breast Cancer
December 12, 2013, Health

Genetic Puzzle Piece for Blood Cancers Found    
December  12,  2013, MedPage Today

Dasatinib Added to Aromatase Inhibitor  Extends PFS in HER2-Negative MBC
December  12,  2013, OncLive
 
Bristol-Myers  Presents Long-term Data on Sprycel - Analyst  Blog
December 10, 2013, NASDAQ
 
Phase III studies demonstrate  superiority of Novartis' Tasigna over Glivec in newly diagnosed Ph+ CML  patients
December 10, 2013, Pharmabiz.com

Preliminary Results from Bio-Path  Holdings’ Phase I Clinical Trial Presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans
December 9, 2013, Business  Wire
 
ARIAD Loses as  EMA Deliberates on Iclusig - Analyst  Blog
December 9, 2013, Zacks.com,
 
Four-Year Data from Phase 3 DASISION  Trial Comparing Sprycel® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Presented at  ASH  2013
December 9, 2013, Business  Wire

Excitement Over CAR-Engineered T-cells  in Leukemia and Lymphoma
December 9, 2013, Medscape

Novartis: Data  Support Superiority Of Tasigna Over  Glivec
December 9, 2013, RTT  News

Gene therapy scores big wins against  blood cancers
December 8, 2013, CourierMail.com

Why Observing  Treatment Milestones is an Individual  Decision
December  8,  2013, Curetoday.com

Penn Medicine Team Reports Findings from Research Study of First 59 Adult and Pediatric Leukemia Patients Who Received Investigational, Personalized Cellular Therapy CTL019
December 7, 2013, Penn Médicine

Gene therapy scores big wins against  blood cancers             VIDEO
December 7, 2013, CBSNews

Update on current monitoring  recommendations in chronic myeloid leukemia: practical points for clinical  practice
December 6, 2013, Hematology

India: No  compulsory licence without reasonable  efforts
December 6, 2013, Managing Intellectual  Property

EU Starts  In-Depth Review of Troubled Leukemia  Drug
December 6, 2013, Medscape

Efficacy and safety of dasatinib versus  imatinib in the East Asian subpopulation of the DASISION trial of newly
diagnosed chronic myeloid leukemia in chronic  phase
December 2013, DocGuide.com

Six Common Misconceptions about the  Chronically  Ill
December 5, 2013, Psychology  Today

Hoof Prints:  Family stays positive despite tough  diagnosis
December 4, 2013, Stillwater  Gazette
 
Park Ridge Timmer Walk raises $50000 to fight blood cancers
December 4, 2013, Deerfield  Review
 
Why Are Cancer Drugs  Commonly The Target Of Schemes To Extend Patent  Exclusivity?
December  4, 2013, Health  Affairs

Researcher seeks to identify the pathway  that leads to cells forming into an individual body
December 3, 2013, National Science  Foundation

Alston Wins  Comeback Player of Year
December 2, 2013, New England Soccer Today

ALL THE WAY  BACK Revs' Alston is MLS Comeback Player of the Year
December 2, 2013, New England Soccer  News
 
Glivec Generics May Be Delayed In The  U.S. - Buy Novartis
December 2,  2013,  Seeking Alpha

Revs' Kevin Alston wins MLS Comeback Player of the Year
December 2, 2013, Boston Herald

Researchers  developing DNA test for tainted pot
December 2, 2013, natmonitor.com

Fund-raising  event in Madison offers trips to Alaska, Grammys, New York
November 29, 2013, New Jersey  Hills

Negative NICE  appraisal of Pfizer's Bosulif for CML
November 27, 2013, The Pharma Letter

Study: Women With Allergies Have Increased Blood Cancer Risk
November 26, 2013, Cancer  Network

FDA Cancer Czar  Floats Change to Drug Review Process
November 26, 2013,  Scientific American

Advocates Lobby  for Continued Access to Ponatinib in  US
November 26, 2013, Medscape

Patients'  advocates press FDA to retain lifesaving drugs  (Iclusig)
November 24, 2013, Boston  Globe

Leukemia patient’s last resort is bone  marrow transplant
November 25, 2013, BangaloreMirror

FDA Tells Google-Backed 23andMe to Halt  DNA Test Service
November 25, 2013, Bloomberg

Ariad jumps on  European drug action
November 23, 2013, Boston  Globe

European Medicines Agency recommends  changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise
risk of blood clots
November 22, 2013,  European Medicine  Agency

Waterloo girl  receives trip of a lifetime
November 21, 2013, hngnews.com

Ponatinib demonstrated activity in  patients with CML,  Ph+ALL
November  21, 2013, HemOnctoday

Ohio Senate's  parity bill for chemo going slow
November 19, 2013, Norwalk  Reflector

Sanofi halts trials of Fedratinib cancer  inhibitor
November 18, 2013, MarketWatch

Ohio Senate's  parity bill for chemo going slow
November 18, 2013 , Columbus  Dispatch

Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies
November 15, 2013, Journal Blood

San Francisco turns into Gotham City for  Batkid (5-year-old with leukemia )
November 15, 2013, Daily  News

Cancer diversity has 'huge  implications'
November 15, 2013, News  Health

Monitoring treatment response is crucial in leukemia management
November 15,2013, Inquirer.net

Improving access to leukemia treatments
November 15,2013, Inquirer.net
​
Madison based  fund-raising event offers trips to Alaska, Grammys, New  York
November 15, 2013, New Jersey Hills

Ariad  Pharmaceuticals unveils plan to conserve cash
November 12, 2013, Boston  Globe

Ruth Tresnak, of Aurora, was elected to the Board of Trustees of The Leukemia & Lymphoma Society Greater Illinois Chapter  --  Health Briefs: Alzheimer’s, veterans,  diabetes
November 11, 2013, The Beacon-News

PRAC updates on the risks of serious  vascular occlusive events associated with cancer medicine  Iclusig
November 8, 2013, European Medicines  Agency

More on Ponatinib and Next Steps - Harry Erba, MD             VIDEO
November 7, 2013, NationalCMLSociety

With sales of its leukemia drug halted,  troubled Ariad cuts 40 percent of US workforce
November 7, 2013, Boston.com

Market Removal  of Ponatinib Raises Questions, concerns
November 7, 2013, Medscape

Managing BCR-ABL Inhibitor Associated Skin Rash     VIDEO
November 5, 2013, Onc  Live
 
Interaction Between Two Leukemia Drugs  Explained
November 5, 2013,  Science Daily

When High Hopes for New Cancer Drugs Are  In Limbo
November 4, 2013, Andrews’Blog

Considerations for Patients Taking Ponatinib - Michael Mauro,  MD       VIDEO
November  5, 2013, NationalCMLSociety

MLS Player and Movember Bro is a Cancer  Survivor Himself
November 5, 2013, Mens  Fitness

Boston Marathon survivor Dave Fortier won't forget the bombing victims when he races to the finish in New York
November  2, 2013, Daily News

FDA Asks for Halt in Sales of Blood Cancer Rx
November 1, 2013, dailyRx

Doctors Fear  Losing Leukemia Drug Deemed Risky
November 1, 2013, New York  Times

The Leukemia  & Lymphoma Society  Issues Statement Regarding the Status of Iclusig
November 1, 2013, DigitalJournal.com

Bone Drug Kills  Leukemia in Mice
November 1, 2013, Bioscience  Technology
victing Leukemia - Bone drug kills resistant cancer stem cells by making home unlivable
October 31, 2013. Harvard medical school

Ariad Suspends Sales of Cancer Pill  Iclusig
October 31, 2013, abcNews

Serious Danger  of Blood Clots Halts Sale of Leukemia Drug
October 31, 2013,  New York  Times

Genetic details  of leukemia resistance
October 31, 2013, Oncology Nurse  Advisor

Ariad  Pharmaceuticals, Inc. (ARIA): Ariad Is Rising With Catalysts  Approaching
October 31, 2013, Seeking  Alpha

Unique  Considerations With TKIs for Chronic Myelogenous Leukemia
October 25, 2013, OncLive

Morningside's Granatowicz battles back from cancer 
October 24, 2013, JournalStar.com
    
The Cost of Living - New drugs could  extend cancer patients’ lives
October 20, 2013, New York News&  Politics

Ariad  announces discontinuation of a trial for its leukemia  drug
October 18, 2013, boston.com

Late-Stage Ponatinib Study  Discontinued
October 18, 2013, OncLive

Ariad Halts  Iclusig Trial; Shares Plunge Over 38%
Oct 18, 2013,  NASDAQ

Ariad Stops  Phase 3 Epic Trial Of Iclusig In Patients With Newly Diagnosed  CML
October 18, 2013, RTT  News

Ariad crushed  (again) after PhIII Iclusig trial is shuttered on blood clot  fears
October 18, 2013, FierceBiotech

Informative Speech on  CML     VIDEO
October 15, 2013, Taylor  May

This Amino Acid Reverses Nerve  Damage
October 15, 2013, institutefornaturalhealing.com

Cell Therapeutics Adds Three Leaders in  Blood Cancer Research and Development to Scientific Advisory  Board
October 14, 2013, Sys-Con Media

Some Cancer Patients May Overdo Oral  Meds
October 13, 2013, MedPage  Today

Taubman  Institute gives $100K grant to cancer  scientists
October 12, 2013 The Michigan  Daily       

Blood Clots in  Trial Prompt FDA Alert on Iclusig
October 11, 2013, Medpage  Today

Inclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And  Veins
October 11, 2013, FDA

Ariad's Nasty Surprise Gives The  Sellside Pause For Thought
October 9, 2013, Seeking  Alpha

Safety Concerns Halt Ponatinib  Development
October 9, 2013, Onc  LIve

DelMar Pharma talks to Life Sciences IP  Review (LSIPR) about creating new patents for shelved drugs to streamline path
to patients
October 9, 2013, PR  Newswire

Novartis A.G. V Union of India - The  Gleevec Case and Evergreening
October 8 2013, Lexocology

Verastem Targets Cancer Stem  Cells
October 8, 2013, Onc  LIve

Chronic Myeloid Leukemia: MDC  Researchers Uncover Why the Disease Progresses and Becomes Resistant to Drug
Treatment
October 8, 2013, HeathCanal

Going the extra mile to honor a Griffin Hospital  volunteer
October 8, 2013,  Shelton  Herald

Two Mutations Help Leukemia Escape  Drugs
October 7, 2013, Drug Discovery  Development

Battling defiant leukemia cells
October 7,  2013,  EurekAlert

Bone Marrow  Transplant - a Donation That Saves a  Life
October 7,  2013,  AllAfrica.com
 
Old friends &  marathons
October 5, 2013, Great Bend  Tribune

Improving access to leukemia  treatments
October 4, 2013,   Philippine Daily Inquirer

Madison to walk against cancer Sunday
October 2, 2013, New Jersey  Hills

Ambit milestone draws near
October 2, 2013, UT San  Diego

Is there a diet for white blood cells or  neutropenia?
October 1, 2013, University of Michigan Health  System

"Jump in For a Cure" Raises Funds for  The Leukemia and Lymphoma Society 
September 29, 2013,  PotageLife.com
 
World Chronic Myeloid Leukemia Day:  ‘Leukemia common among younger Pakistanis’ 
September 27, 2013, The Express Tribune

Twin pregnancy and childbirth after  reduced-intensity conditioning allogeneic haematopoietic stem cell
transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review
September 26, 2013,  CBMTG

JAK of all trades: JAK2-STAT5 as novel  therapeutic targets in BCR-ABL1+ chronic myeloid  leukemia
September 26, 2013, Journal  Blood

With $1 billion hanging in the balance,  Knight Cancer Institute must show its best  nationwide
September 24, 2013, Oregon  Live

Novartis provides update from treatment-free CML  trial
September 23, 2013,  Zenopa

Targeted drugs extend cancer patients’  lives
September 23, 2013, Taipei  Times

Graphic letters to judge pin residents’  illnesses on Tonawanda Coke
September 23, 2013, The Buffalo  News

Lebanese  scientists hope for breakthrough against leukemia
September 21, 2013, The Daily  Star

Novartis  progresses with clinical trials in chronic myeloid  leukemia
September 19, 2013, ThePharmaLetter

Ariad Pharma:  Dismantling The Short Thesis
September 19, 2013, TheStreet.com

Hallmarks of Cancer 1: Self-Sufficiency in Growth Signals
September 18, 2013, Scientific  American

Imatinib cessation in children and  adolescents with chronic myeloid leukemia in chronic  phase
September 17, 2013, Pediatric Blood &  Cancer

Dr. Druker,  Reps. Capps and King to Receive AACI Awards
September 16, 2013, Newswise

Immune system  marker tied to improved bone marrow transplant  outcomes
September 16, 2013, HealthCanal.com

ARIAD is leasing more space at new  Kendall Square facility, Alexandria says
September 16, 2013,  Boston.com

Oral Oncolytics: Part 2—Legislation  Targeting Cost & Access, and Other Initiatives to Reduce  Costs
September 15, 2013, Cancer  Network

Trial Suggests Imatinib Discontinuation Safe, Some Responses  Persist
September 15, 2013, Cancer  Network

'Bristol-Myers misleading HC in patent case'
September 14, 2013, Times of  India

Dasatinib Shows  Promise for Pediatric CML, ALL  Patients
September 13, 2013, Cancer Network

Interesting  turn in Dasatinib patent war
September 12, 2013, Times of  India

Conneaut eighth  grader conquers childhood cancer
September 12, 2013, The Star  Beacon

BDR Pharmaceutical's plea for compulsory licence on cancer drug rejected
September 12, 2013, The Economic Times

Gambia: Two-Year-Old Boy Seeks Medical Assistance
September 11, 2013, allAfrica

Does This Orphan Leukemia Treatment Have  Blockbuster Potential?
September 11, 2013, The Motley  fool
 
Local fundraising team hopes to help  fund fight against leukemia
September 11, 2013, Hudson Hubs  Times

Panel backs  compulsory licence on cancer drug
September 11, 2013, Livemint

What’s on the news this  morning
September 10, 2013, Destiny  Connect.com

Novartis Ties Up With Regenerex
September 10, 2013, Zacks

Rare, Inherited Mutation Leaves Children  Susceptible to Acute Lymphoblastic  Leukemia
September 9, 2013, Science  Daily

Generic cancer drug - access not  guaranteed
September 9, 2013, Mail  Guardian

GALLAGHER: Year after tackling leukemia,  Morningside linebacker returns to field in Sioux  City
September 8, 2013, Sioux City  Journal.com

Madison  Superintendent Rossi to be honored at Martell  walkathon
September 6, 2013, New Jersey  Hills

ARIAD enrolls 50% of patient planned in phase III EPIC trial of Iclusig
September 6, 2013,  Pharmabiz.com

Impressive thrombocytosis evolving in a  patient with a BCR-ABL positive CML in major molecular response during dasatinib
treatment unmasks an additional  JAK2V617F
September 5, 2013, Experimental Hematology &  Oncology

Otsuka to buy cancer biopharma  Astex 
September 5, 2013, PMLive

​Survivor's story goes  public
August 31, 2013,  RecordOnline.com
 
New Strategy Against High-Risk  Leukemia
August 29, 2013, Science  Daily

Anthony Pawson,  Biologist in Cell-Protein Breakthrough, Dies at 60
August 29, 2013 , New York  Times

Study yields new strategy against  high-risk leukemia
August 29, 2013, Medical  Xpress
 
Chronic Myelogenous Leukemia: Anchoring  ABL for a Better Fate
August 27, 2013, Science  Daily

Anchoring ABL for a better fate
August 27, 2013, Medical  Xpress

Imatinib discontinuation safe in CML patients with durable  response
August 23, 2013, Healio

Martell Foundation seeks walkathon  volunteers in Madison
August 23, 2013, Madison  Eagle

This Small Company Is Winning the War  Against Blood Cancer
August 21,2013,  Daily Finance

Ruxolitinib Plus Capecitabine Improves  Survival in Pancreatic Cancer
August 21, 2013, OncLive

The treatment: Improving on success
Summer 2013,   MD Anderson  Cancer Center

The Philadelphia Chromosome: A Mutant  Gene and the Quest to Cure Cancer at the Genetic Level’ by Jessica  Wapner
August 16, 2013, The Washington  Post

Dr. Anton Bilchik Discusses New Cancer  Treatments
August 16, 2013, Prleap

First-Line Treatment for Patients With  CML in Chronic Phase: Why Imatinib Is an Appropriate  Choice
August 15, 2013, Cancer  Network

Former Hudson man named Man of the Year  for Arizona Leukemia and Lymphoma Society
August 14, 2013, Hudson  Hub-Times

Ottawa researchers hopeful  nano-particles can cure leukemia
August 13, 2013, CTV  News

ASCO 2013: Humanity Meets  Immunity
August 13, 2013, OncLIve

Tony Pawson, internationally acclaimed Canadian scientist, dies at 60
August 9, 2013, The Globe and  Mail

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
August 8, 2013, Journal Blood

Jerry  Mayfield – Lost of a CML  warrior 
August 8, 2013, NationalCmlSociety

Ponatinib—A Step Forward in Overcoming  Resistance in Chronic Myeloid Leukemia
August 5, 2013, Clinical cancer  Research

A pastor retires: Looking back on 46 years of 'the best job in the Catholic Church'. Five years ago he was diagnosed
with CML.
August 2, 2013, Deseret News

Measuring the symptom burden associated with the treatment of chronic myeloid leukemia
August 1, 2013,  Journal Blood

What  challenges remain in chronic myeloid leukemia  research?
August  1, 2013, Haematologica

Routine  Monitoring for MRD in Leukemia? It's  Coming
August 1, 2013, Medscape,

Has Carl June Found a Key to Fighting  Cancer?
August 2013, The  Phillymag.com

WATCH: Pro  Wakeboarder Fights Chronic Myeloid Leukemia Daily to Reach  Goals
July 31, 2013, Huffington   Post

Let's Talk About Kevin Alston and the All Star Game
July 31 2013, Big D Soccer

Cancer cells in bull's-eye
July 30, 2013, Florida  Today

Leukemia–going for the  cure!
July 29, 2013,  ExpertClick

Kevin Alston makes his  return
July 28, 2013, boston.com 

Perspective: Combined  forces
June 27, 2013, Nature
 
Derby organizers pay tribute to  long-time drivers at fair
July 26, 2013, Journal  News

Effects of food on the pharmacokinetics  of ponatinib in healthy subjects.
July 25, 2013,  PublMed

Safety and efficacy of imatinib  cessation for CML patients with stable undetectable minimal residual disease:
results from the TWISTER study
July 25, 2013, Journal  Blood

State of CML  Treatments
July 25, 2013, CancerNetwork

5-year-old  cancer patient receives new playground
July 25, 2013, DailyPress

Eugene Jeans Guy Upbeat Despite  Cancer
July 25, 2013, EugeneWeekly.com

Why We Still  Haven't Won the War on Cancer
July 24, 2013,  Everyday  Health
 
Kids with cancer: Part III: You can help  raise money to find a cure
July 23, 2013, SyracuseParent.net
 
Bio-Path Holdings Initiates Development  of Liposomal Grb-2 for Triple Negative and Inflammatory  Brea
July 22, 2013, Daily  Finance

Royal Society accolades for Manchester scientists - GlaxoSmithKline Prize. Dr Nicholas  Lydon
July 22, 2013, University  of  Manchester
 
Biomarkers for  determining the prognosis in chronic myelogenous  leukemia
July 19, 2013, 7thSpace  Interactive

Despite leukemia, artist continues to  create music
July 17, 2013, The Daily  Times

Kevin  Alston, treated for leukemia, talks about New England  Revolution return   VIDEO
Jul 17, 2013, ProSoccerWalk

Kevin Alston  back on the Revolution roster
July 17, 2013, Boston Globe

Novartis  2nd-quarter in line with analysts'  forecasts
July 17, 2013, The Pharma  Letter

Negative NICE news for Pfizer leukemia drug
July 16, 2013, The Pharma  Letter

Northfielder credits blood donation with  early cancer diagnosis
July 16, 2013, Northfield  News

Homoharringtonine Induction Therapy for Treatment-Naïve  AML 
July 2013, Clinical Oncology  News

TWIST it but don’t spin  it
July 25, 2013, Journal  Blood

Pfizer faces  NICE rejection for cancer drug Bosulif
July 16, 2013, PMLiVE

Where Next for  TKIs in CML? EHA Data and Expert Opinion
July 15, 2013, Medscape

Brandon  Jauregui: Finding the fight
July 15, 2013 , Santa Clarita  Valley  Signal

Billion-Dollar  Savings Projected From Biosimilars
July 15, 2013, Pharmacy Practice News

After treatment for leukemia, New  England Revolution's Kevin Alston removed from Disabled  List
July 15, 2013, Mls  soccer.com

Recently Released Market Study: PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market
Analysis to 2022
July 15, 2013, SBWire

Brides Project fights cancer with satin and lace
July 13, 2013, The Town Talk.com

EUTOS Score  Validated for Predicting Treatment Outcomes With TKI  Therapy
July 12, 2013, Cancer  Network

Martell  Foundation seeks Madison walkathon  volunteers
July 11, 2013, New Jersey  Hills

Recently Released Market Study: Sprycel  (Chronic Myeloid Leukemia) - Forecast and Market Analysis to  2022
July 11, 2013, SBWire
 
Ponatinib Receives Marketing Authorization in Europe for CML and Ph+ ALL
 July 11, 2013, Cancer  Network

Developing  Novel Treatments Using the AML Genome
July 10, 2013, Cancer  Network

Project fights  cancer with satin and lace
July 9, 2013. USA  TODAY

A Battle Against Wayward  Genes
July 4, 2013, The Wall Street  Jounal

New  Market Research Report:  PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain  Drug Forecast and Market
Analysis to 2022
July 4, 2013, SBWire

My Survivor Story: Mark Popadick,  Chronic Myelogenous Leukemia Survivor    VIDEO
July 2, 2013, Memorial  Sloan-Kettering

ARIAD Announces Marketing Authorization for Iclusig® (ponatinib) in the European  Union
July 2, 2013, Daily  Finance

World War  Cancer
July 1, 2013, The New Yorker

QOL issues affect patients with CML  taking oral chemotherapy
July 1, 2013, Oncology Nurse Advisor   

wo CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic  remission after treatment with imatinib mesylate.
June 2013, PublMed  

European LeukemiaNet recommendations for the management  of chronic myeloid leukemia: 2013
June 26, 2013, PublMed

No More Chemo: Doctors Say It’s Not So  Far-Fetched
June 26, 2013, Time  Health & Family

FDA Updates  Dasatinib Label for Chronic Myeloid Leukemia
Jun 26, 2013, Medscape

BCR-ABL1 kinase domain mutations may persist at very low levels for  many years and lead to subsequent TKI  resistance.
June 25, 2013, PublMed

Why Don't Cancer Patients Take Their  Oral Medicine?                VIDEO
June 24, 2013,  Patient Power·

Bristol-Myers  Squibb gets a boost for leukemia drug  Sprycel
June 21, 2013,  FiercePharma

New Follow-Up Data for Sprycel Among the Longest for CML
June 21, 2013, MPR

Tools& Techniques: Quantum Dot-based  microRNA Detection; siRNA Delivery to Leukemia Cells; and  More
June 20, 2013, Genome  Web

TKI Therapy  Affects Quality of Life in CML  Patients
Jun 20, 2013, Medscape

Doctors At Ohio State Witness Leukemia  Breakthrough
June 19, 2013, 10TV.com

Cancer Risk From CT Scan  Radiation           VIDEO
June 19, 2013, NutritionFacts.org·

Leuka Chairman reports from  Stockholm
June 18, 2013,  Leuka

New Market Report: PharmaPoint: Chronic  Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to  2022
June 17, 2013, SBWire

CML Experts Raise Industry Hackles by  Decrying High-and-Rising Costs of Treatments
June 15, 2013, Genetic Engineering Biotechnology News

Imatinib Discontinuation in Chronic Phase CML Doesn’t Always Lead to Relapse
June 14, 2013, Cancer  Network

Intermittent Imatinib for Elderly CML  Patients Shows Promise
June 14, 2013, Cancer  Network

Emerging Therapeutic Strategies for  Targeting Chronic Myeloid Leukemia Stem  Cells
June 13, 2013, Hindawi

Curing Cancer: The Philadelphia Award  and Dr. Carl June   VIDEO
June 11, 2013, Rich Tolsma  Productions

Excellent therapeutic results achieved  in chronic myeloid leukemia patients with front-line imatinib and early
treatment modifications in suboptimal responders: A retrospective study on 91  unselected patients.
June 11, 2013, PublMed

Quality-of-life issues need to be addressed for CML patients, Moffitt researchers  say
June 10, 2013, Science  Codex

Quality-of-life issues need to be  addressed for CML patients, researchers  say
June 10, 2013, MedicalXpress

Society, GRU  doctor work to cure leukemia
June 9, 2013,  Aiken Standard

Kareem Abdul-Jabbar on life beyond the court   VIDEO
June 9, 2013, CBSnews

Emily Grider fights leukemia; fundraiser set
June 6, 2013, The Star  Press

PharmaPoint: Chronic Myeloid Leukemia  (CML) - US Drug Forecast and Market Analysis to  2022
June 6 2013, USPRWIre

Targeted cancer therapy pioneers tapped  to receive the 2013 $100,000 Taubman  Prize
June 5, 2013, PRNewswire

Research and Markets: Gleevec (Chronic  Myeloid Leukemia) - Forecast and Market Analysis to  2022
June 5, 2013, Fort Mills  Times

Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market
Analysis to 2022
Jun. 4, 2013, Fort Mills  Times

New Drug Target Identified For Treating Deadly Form Of Leukemia
June 4, 2013, AsianScientist
 
Singapore research team identifies new drug target in deadly form of leukemia
June 3, 2013, EurekAlert

Research and Markets: PharmaPoint:  Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to  2022
Jun. 3, 2013, Fort  Mills  Times

ARIAD Announces Long-Term  Durability-of-Response Data on Ponatinib from Ongoing Phase 1  Study
Jun 2, 2013,  DailyFinance

ARIAD Presents Analysis of  Cardiovascular Risk Profile of Patients from Pivotal PACE Trial of Iclusig ® (Ponatinib)
Jun 1, 2013, Daily  Finance

Research and Markets: PharmaPoint Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to  2022
May. 31, 2013, Fort Mill  Times

Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers
at ASCO and EHA
May 29, 2013, FierceBiotech

The BCR-ABL T315I mutation compromises  survival in chronic phase chronic myelogenous leukemia patients resistant to
tyrosine kinase inhibitors, in a matched pair  analysis
May 28, 2013,  Haematologica

American Cancer Society Legends: Dr.  Brian Druker         VIDEO
May 28, 2013, American Cancer  Society
 
Going one-on-one with Kareem Abdul-Jabbar
May 28, 2013, Bay Area, Biz Talk

Revs, fan group  to hold trivia night in support of Alston and his leukemia  battle
May 28, 2013, Boston.com

Run4Beka raising funds for cancer  group
May 28, 2013, Santa Ynez Vallez  News

Revolution, Fans To Hold Trivia Night Fundraiser in Support of Kevin Alston, Leukemia and Lymphoma Society on May  30
May 26, 2013, NESN

Skyhook king,  Abdul-Jabbar, in town to support leukemia fight
May 25, 2013, San Jose Mercury  News

Safety and efficacy of imatinib  cessation for CML patients with stable undetectable minimal residual disease:  results from the TWISTER Study
May 23, 2013, PublMed

Man's dream of marriage comes true even  as he fights cancer
May 22, 2013, WDRB.com

Bankruptcy or Cure? A Cancer Patient's  Dilemma
May 22, 2013, Medscape Today

Ariad's Cancer Drug Iclusig Extends The  Gleevec Magic
May 22 2013, Seeking  Alpha

Teen Develops Computer Algorithm to Diagnose  Leukemia
May 21, 2013,  Mashable

18-yr-old teaches computer to diagnose  cancer
May 21, 2013,  rappler.com

Dawn Tyler Watson headlines all-star  Blues for Life concert to benefit  leukemia survivors
May 21, 2013, Montreal  Gazette

New leukemia mutation offers therapeutic  targets
May 21, 2013, 2 minutes  medicine

QuantuMDx, A*STAR  To Develop Asia-Specific Genetic Tests
May 21, 2013, Asian  Scientist

CML Drug Revenue in Japan to Grow,  Despite Global Decline
May 20 2013, Pharmiweb.com 

Tackling  Cancer: Leukemia's Biggest Current and Upcoming  Players
May 19, 2013, Motley  Fool

Cancer Drug  Prevents Build-up of Toxic Brain Protein
May 16, 2013,  HealthCanal.com

Woman with  leukemia meets researchers of her life-saving  drug
May 16, 2013 , UPI.com
 
The cost of my cancer  survival
May 16, 2013, timesunion.com

Albany Medical Center to award Prize in  Medicine and Biomedical Research Friday
May 16, 2013, The  Record

How I Manage:  Chronic Myeloid Leukemia
May 2013, Clinical Oncology  News
 
Faith, family  help Brooks fight leukemia
May 16, 2013, ThisWeekNews

Discovery pinpoints cause of two types  of leukemia, providing insights into new treatment approach
May 14, 2013, HeathCanal

Nilotinib  Associated With Increased Peripheral Artery Disease Rate in CML
May 13, 2013, Cancer  Network

Mice Study Finds Cancer Drug May Work on Common Brain  Diseases
May 13, 2013  PsychCentral.com

Direct hit on  cancer
May 12, 2013, New York  Post

Targeting of the MNK–eIF4E axis in blast  crisis chronic myeloid leukemia inhibits leukemia stem cell  function
 May 10, 2013, PNAS

Mouse study shows leukemia halts  accumulation of toxic proteins linked to Parkinson's  disease
May 10, 2013, News  Medical

Cancer treatments "unaffordable" and  will drive rapid transition to generics and market decline, says  GlobalData
May 10, 2013, the  pharmaletter

The Story  Behind a Miracle Cancer Drug [Excerpt]
 May 10, 2013, Scientific  American

Discovery  pinpoints cause of two types of leukemia - Science  Daily
May 10, 2013, Science  Daily

Early molecular response and female sex  strongly predict stable undetectable BCR-ABL1, the criteria for imatinib
discontinuation in patients with CML
 May 9, 2013, PublMed

Mutations in  CSF3R common in CNL, atypical CML - Medical  Xpress
May 9, 2013, Medical  Xpress

New leukemia mutation offers therapeutic  targets
May  8, 2013, 2 minutes  medicine

Do Blood  Cancers Need Prophylactic Platelet Transfusions? -  Medscape
May 8, 2013, Medscape
           
High costs of  leukemia may be harming patients
May 7, 2013, Oncology Nurse  Advisor

The  Model Approach to Drug Development
May 6, 2013, Bio It  World

Ruling thrills patients and boosts Indian generic drug  makers
May 6, 2013, Smart  Planet

Gene expression profiling of  chronic myeloid leukemia with variant t(9;22) reveals a different signature from  cases with classic translocation
May 4, 2013, 7th  Space

Pharmaceutical  Companies Profits Reach 30 Percent, Author  Says
May 3, 2013, The Lund  Report

LLS - Brian Druker,  MD
May 2, 2013, LeukemiaLymphomaSoc·

News from the Front in War on  Cancer--Mission Not Accomplished
May 2, 2013, , Scientiific  American

Are CML Drugs  Priced Out of Reach?
May 2, 2013, Cancer  Network

News from the  Front in War on Cancer--Mission Not  Accomplished
May 2, 2013, Yahoo! News

Essential profits vs. medical profiteering
May 1, 2013, Journal  Inquirer

The Beginning of the End of the Beginning in Cancer  Genomics
May 1, 2013, The New England Journal of  Medicine

Genomic Mutation Studies Unlock Details on Cancers 
May 1, 2013, The Wall Street  Journal

Exorbitant  Prices for Leukemia Drugs
May 1, 2013, New York  Times

PITTS: When  generics win, patients lose
May 1, 2013,  Washington  Times

Ponatinib  Excels in Heavily Pretreated  Population
April 2013, Clinical Oncology  News

The real cancer  killer: rip-off prices for drugs
April 29, 2013, The  independent

Drug industry 'profiteering' threatens  lives
April 29, 2013, News Mail

Leukaemia drug  prices "unsustainable" say cancer  experts
April 29, 2013, PMLive

Scientists  Challenge Pharmaceutical Companies On Drug  Pricing
April 29, 2013, OPB News

Doctors rebel  against rip-off drug costs - Consumer Reports  News
April 29, 2013, ConsumerReports.org
 
A Tale Of Three  Pharmaceuticals: Getting Exciting In  2013
April 29, 2013, Seeking  Alpha

Improved tolerability by a modified  intermittent treatment schedule of dasatinib for patients with chronic myeloid
leukemia resistant or intolerant to  imatinib.
April 28, 2013, Publmed

How Much Is  Your Life Worth? - San Diego Free  Press
April 28, 2013, San Diego Free  Press

Doctors around the world criticize drug companies for high cost of life-saving  pills
April  27, 2013,  abc action news

Lifestyle and Dietary Factors in  Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health  Study
April 26, 2013, Publmed

Doctors blast  ethics of $100000 cancer drugs
April 26, 2013, CNNMoney

Are $100000  cancer drugs unethical?
April 26, 2013, The  week

Top Oregon Health & Science  University researcher to doctors: Rise up over drug  prices
April 25, 2013, OregonLive

Cancer Doctors Raise Pressure On Pharma  Industry To Cut Drug Prices
April 25, 2013, Forbes

Chronic Myeloid Leukemia Market Explored  in New Cutting-Edge GlobalData Study Published at  MarketPublishers.com
April. 25, 2013,   Fort Mills Times

Leading leukemia experts: High leukemia treatment costs may be harming  patients
April 25, 2013, Eurekalert

DelMar IPO  Obscurity Could Offer Investors Favorable  Entry
April 24, 2013, Seeking  Alpha

Lehigh Valley  students take top honors at regional research event
April 23, 2013, Penn State News

A population study showing that the advent of second generation  tyrosine kinase inhibitors has improved progression-free survival in chronic  myeloid leukaemia
April 22, 2013,  PubLMed

Hope for Karen  wrestling benefit in Millersville  Friday
April 22, 2013, Examiner.com

One-on-one with Kareem  Abdul-Jabbar
April 22, 2013, redeyechicago

Vanderbilt Patients Collaborate With  Nashville’s Music Row Superstars To Bring Their Songs To  Life
April 22, 2013, Newswise

In a first,  Rajasthan govt to provide free leukemia  drugs
April 21, 2013, Times of  India

Landmark  verdict
April 20, 2013, Frontline

Novartis Indian Supreme Court judgment:  what is efficacy  for pharmaceutical  invention?
April  19 2013, Lexocology

What Makes a  Good Founder? Hint: it's in the  details
April 19, 2013 , Forbes
 
More research needed on causes of  leukemia, as growing lifespan of patients enables study, says  GlobalData
April 18,  2013, the  pharmaletter

Janet Rowley shares prestigious medical  prize with cancer treatment pioneers
April 17, 2013, UChicagoNews 

New Mechanism of Resistance Identified  in Brain Tumors
April 17, 2013, OncLive

C. William  Johnson, band director
April 17, 2013, Washington  Post

Scientist wins  Albany prize for leukemia cell  research
April 17, 2013, Chicago  Tribune

Cancer research pioneers to share $500K  Albany Med prize
April 16, 2013, timesunion.com

Long-Term Treatment With Imatinib Affected Bone Mineral Density
April 16, 2013, CancerNetwork

Chronic  Fatigue Limits Quality of Life in Imatinib-Treated CML  Patients
April 16, 2013, Cancer Network

Long-Term  Treatment With Imatinib Affected Bone Mineral  Density
April 15, 2013, Cancer  Network

Teenager Died From Leukemia Days After  Misdiagnosis
April 15, 2013, The  Inquisitr

AVEO Poised To Move Higher Before May 2  FDA Adcomm Catalyst, Obama Care, And Platform  Potential
April 15, 2013, Trefis

A dose of  transparency
April 15, 2013, The Indian Express

Pharmaceutical  companies must balance profits and  affordability
April 14, 2013, The New Indian  Express

Cancer 'parity'  bills churn through Florida  Legislature
April 13, 2013, The Miami  Herald 

TASIGNA (nilotinib) - Possible Risk of  Developing Atherosclerosis-Related Conditions - For the  Public
April 12, 2013, Health Canada

Glasford  inspires runners, donors to join fight against blood  cancer
April 12, 2013, NCNewsPress.com

Nilotinib for  CML Leads to Fewer Treatment-Emergent Mutations Than  Imatinib
April 12, 2013, Cancer  Network

Patients or  patents?
Apr 12,  2013.   Livemint

Teenager dies of leukaemia ten days  after tonsillitis diagnosis
April 11, 2013, Metro

Why Chemotherapy That Costs $70,000 in  the U.S. Costs $2,500 in India
April 10, 2013, The  Atlantic

Drug sales reps often don't inform docs  about adverse effects: Study
April 10, 2013,  lfpress.com

The Cost of  Cancer Drugs and Research
April 9, 2013, Huffpost Healthy  Living

Nilotinib  associated with fewer BCR-ABL mutations in chronic phase  CML
April 9, 2013, Healio

Prof. Levitzki chosen for American Cancer Research Award
April 9, 2013, IsraelNationalNews

ARIAD Pharmaceuticals presents  preclinical data on ponatinib at AACR Annual Meeting  2013
April 9, 2013,  NewsMedical

ARIAD’s leukemia drug Iclusig may be  used in other cancer treatments
April 8, 2013, bioflash

Take the Skyhook Challenge and Help Beat  Blood Cancer -The Leukemia & Lymphoma Society Helps Launch Contest to Honor  NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood  Cancer
April 8, 2013, PRNewswire

ARIAD Presents New Preclinical Data  Showing Ponatinib is a Potent Inhibitor of RET and FGFR, Two Oncogenic Drivers
of Non-Small Cell Lung Cancer
April 8, 2013,  Fort Mill Time

New England Revolution defender Kevin Alston diagnosed with treatable form of  leukemia
April 8, 2013, MLSsoccer.com

HU biochemistry professor to receive major award
April 7, 2013, Jerusalem Post

Dr. Hagop Kantarjian Receives the 18th  Annual AACR Joseph H. Burchenal Memorial  Award
April 6, 2013, American Association for Cancer  Research

CML-Living with a Chronic  Disease
April 5, 2013,   PRNewswire

Novartis Loses Historic India Patent Case On Cancer Drug Glivec
April 5, 2013, Asian Scientist

Conditional EU Approval for Pfizer's Bosulif - Analyst  Blog
April 4, 2013, NASDAQ

ARIAD's CEO  fights back, defends leukemia drug despite  report
April 4, 2013, Boston Business  Journal
 
A*STAR Scientist Alex Matter Awarded  Prestigious Szent-Gyorgyi Prize For Progress In Cancer  Research
April 4, 2013, News  Maker
 
The Philadelphia chromosome
April 4 2013, live mint

Ariad's Leukemia Drug Toxic, Survey  Says
April 3, 2013m, The  Street

Dr. Alex Matter Awarded 2013  Szent-Györgyi Prize For Progress In Cancer  Research
April 3, 2013,   Asian  Scientist
 
Guest Post: The  Patent Failure of Novartis with Gleevec
April 3, 2013,   Patenty O.

Father of Glivec hails SC ruling
April 3, 2013, The Times of  India

‘Deterred by cost of Glivec, many embraced death’
April 3, 2013, The New Indian  Express

Expression and Function of the Eph  Receptor Family in Leukemia and Hematopoietic Malignancies: Prospects for
Targeted Therapies
April 3, 2013, Journal of  Leukemia

Promising stem cell therapy for leukemia patients
April 2, 2013, MedicalXpress

Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India  MD
April 2, 2013, The Economic  Times

Don't cut lifesaving dollars - Health research and medical progress are in peril amid NIH budget cuts
April 2, 2013, Los Angeles  Times

Glivec ruling: Putting patients before profits
April 2 2013, Live  Mint
 
This will discourage innovative drug discovery, Novartis MD Ranjit Shahani  says
April 2, 2013, Times of  India

Man behind Glivec hails SC verdict
April 2, 2013, Business Standard

Supreme Court Rejects Novartis Appeal; Upholds high standard for Section 3(d)
April 1, 2013, Lawyers  Collective

Transplant  girl: thank you for saving my life
 April 1, 2013,  The  Telegraph

Novartis Loses Glivec Patent Battle in  India 
April 1, 2013, The Wall Street Journal

Novartis: India  rejects patent plea for cancer drug  Glivec
April 1, 2013, BBC  News

Novartis cancer drug patent bid rejected  by Indian court in landmark ruling
April 1, 2013, The  Guardian

India's top  court to deliver Novartis judgment
March 31, 2013, U.S. News &  World  Report

Gene Alfred  Brothers
March 31, 2013 , Amarillo.com

Escalation and Stopping Treatment of Imatinib, Nilotinib or  sprYcel in  Chronic Myeloid Leukaemia  (DESTINY)
March 2013, National Cancer Institute
 
Indian pharma  industry awaits SC verdict on Novartis patent claim on April 1
March 29, 2013,  Indiatvnews.com

Donor lymphocyte infusion for relapsed  hematological malignancies after allogeneic hematopoietic cell transplantation:
prognostic relevance of the initial CD3+ T cel dose
 March 29, 2013, Biol Blood Marrow  Transplant

Low Volume  Volatile Trading Likely Ahead Of Long Weekend
March 28, 2013, RTT  News

Conditional EU  approval for Pfizer's CML drug Bosulif
March 28, The Pharma Letter

Big Pharma waits nervously on India drug patent verdict
March 27, 2013, Reuters

New Monoclonal Antibody Targets  Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer  Network

The 2013 Leukemia Ball Features Dana Carvey and Jim Belushi
March 25, 2013, Washingtontonian

Parents and Children's Hospital  researchers await results on an experimental leukemia gene therapy
March 25, 2013,  philly.com

European Panel  Gives Nod to Leukemia Drug
March 25, 2013,  Medscape Todqy News

East Coast Biotech Roundup: Moderna,  bluebird, Blueprint
March 22, 2013, Xconomy

 ARIAD Announces That Iclusig™  (Ponatinib) Receives Positive CHMP Opinion for Approval in the European  Union
 March 22, 2013, Fort Mill Times

Experimental Cancer Treatment Offers  Hope                VIDEO
March 21, 2013, ABCNews

Can Therapy With TKIs for CML Ever Be Stopped?
March 21, 2013, OncLIve

Researchers  study use of dasatinib for patients with high-risk  MDS
March 21, 2013, Medical Xpress

Cell-Based Immune Therapy Shows Promise  in Leukemia Patients
March 20, 2013. Memorial Sloan-Kettering Cancer  Center

Altered T-Cell Therapy Shows Promise from Acute Type of Leukemia
March 20, 2013, The New York  Times

Blueprint Medicines Combs Through Genome for the Next Gleevec(s)
March 20, 2013, Xconomy

Mumbai company  seeks cancer drug  licence
Mar 19, 2013,  The Times of India

Training for a race is well within  Justin Ozuna’s control — unlike  leukemia
March 18, 2013, The Dallas Morning  News

Novartis' Life-Changing Blockbuster  Drug
March 18, 2013, The Motley  fool

What you need to know about  leukemia
March 17, 2013,   Seacoast  Online

Is the war on cancer an ‘utter failure’?: A sobering look at how billions in research money is spent
March 16, 2013, National  Post

An Interview  With Leo Ehrlich, Cellceutix CEO
March 14 2013, Seeking  Alpha

Labceutics,  Asuragen to jointly conduct pan European study on  CML
March 13, 2013, Pharmaceutical Business  Review

Patient stories  centre stage at cancer summit
March 12, 2013, Benefits  Canada

CML Stem Cell  Burden at Diagnosis Associated With Treatment  Outcomes
March 11, 2013, Cancer  Network

Bio-Path Holdings Begins Enrollment in  Fifth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2
in Leukemias
March 8, 2013, Pharmiweb.com

Major new clinical trial to improve treatment for leukaemia  patients
March 7, 2013, HealthCanal.com

Join the local  fight to cure blood cancer
March 7, 2013, Ventura County  Reporter

Bosutinib Heads  Toward Conditional Approval for CML in  Europe
March 6, 2013 , Cancer  Network

A World Without Cancer: Is Prevention the Cure?
March 6, 2013, The Motley  fool

Occurrence and current management of  side effects in chronic myeloid leukemia patients treated frontline with
tyrosine kinase inhibitors
March 6, 2013, PublMed

Transplant  advocate understands the need,  personally
March 6, 2013, Atlanta Journal  Constitution

Dasatinib thwarts brain cancer metastasis after bevacizumab use
March 1, 2013, Oncology Nurse Advisor

Why Are Investors Excited About  Ariad?
February 28, 2013, Seeking Alpha

Novartis provides multimedia support to Rare Diseases Day
February 28, 2013, PMLiVE

Interest groups barrage Congress with sequester pleas
February 28, 2013, USA Today

Being chronically ill or in pain can  feel like a full-time job
February 27, 2013,  KevinMd.com

Canada: Pharma In Brief - Canada: Federal Court Upholds Validity Of GLEEVEC® Patent - See the decision
February 27, 2013, Mondaq

Predictive factors for successful   imatinib cessation in chronic myeloid leukemia patients treated with  imatinib
February 26, 2013, PublMed

Lottie Duthu - loss of a CML warrior  -  See the Guest Book   
February 25, 2013, CML2

New TKI Ponatinib Effective in Resistant CML
February 2013, Clinical Oncology News

DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
February 25, 2013, Providence Journal

Show helped bride-to-be plan, despite cancer diagnosis
February 25, 2013,  Western Star

After transplant, she's ready to get home
February 24, 2013, Omaha World-Herald

Seahorse Bioscience XF Technology Yields Insights on Leukemia Stem Cell Metabolism and Potential New Leukemia Therapies
February 22, 0213, Providence Journal

Granting wishes
February 22, 2013, Democrat Missourian

Bio-Path Shares are Attractive now - L-Grb-2 is a liposomal delivered antisense cancer drug that targets an multibillion dollar annual market for CML
February 22, 2013, Nasdaq

Leukemia arsenal has new drugs
February 22, 2013, Oncology Nurse Advisor

Lawsuit: Cancer patient didn't  get medication at jail
February 21, 2013, The Salem  News

From Chromosomes To Cures: The Lifesaving Cancer Research  Of Dr. Janet Rowley   VIDEO
February 21, 2013, Chicago Blood Cancer·

Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences
February 21, 2013, News Medical

Court affirms utility of Gleevec patent
February 20 2013, Lexology

Inaugural Breakthrough Prizes Recognize Excellence in Research
February 20, 2013, Howard Hughes Medical Institute

As CML Drugs Improve, Earlier Surrogate Outcome Markers Needed
February 20, 2013, Cancer Network

China sets up first CML molecular testing platform
February 20, 2013, China Daily

Targeting Leukemic Stem Cells in Marrow Could Stave Off TKI Resistance
February 19, 2013, Cancer Network

Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
February 2013, American Journal of Hematology

Igniting the conversation about rare diseases
February 19, 2013, Palatka Daily News

The Philadelphia Chromosome by Jessica  Wapner - Book Trailer   Video
February 15, 2013, experimentpublishing

Show solidarity for International Childhood Cancer Day
February 15, 2013, Wort.lu

Leukemia, the first and second time around
February 15, 2013,  HealthCanal

Use of Digital PCR Ramping Up
February 15, 2013, Gen

Living With Chronic Myeloid  Leukemia
February 14, 2013, dailyRx

Epigenetic inactivation of the MIR129-2 in hematological malignancies
February 14, 2013, 7th  Space

TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA  public workshops
February 13, 2013, PRWeb

Choosing a Tyrosine Kinase Inhibitor in  CML
February 12, 2013, Targeted  Healthcare

Couple fights leukemia together as they  celebrate their first anniversary
February 11, 2013, MD Anderson Cancer  Center

Cancer battle: Scientists engineer new tumor-killing virus
February 11, 2013, RT News

“Borne Out of Necessity and Data”:  Conquering Mutations in Leukemia
February 6, 2013, PLOS  Blog

Scene in Edmonds: The Edsel Hermoso Moscoso Mural (Donation to Max Foundation)
February 9, 2013, My  Edmonds News

One Million Americans with Blood Cancer in Jeopardy of Losing  Access to Needed Medications
February 6, 2013,  PRNewswire

Raymore students help send ailing boy to Disney  World
February 6, 2013,    KCTV

Sandy and Tommy  Edge, with their Valentine's tree in  Baileyton
February 6, 2013, The  Arab Tribune

Wilm’s Tumor Vaccine Effective for  CML
February 5, 2013,  Medical Automation

Chronic myeloid leukemia: Advances in diagnosis and management
February 5, 2013, Journal of  the American Academy of Physician Assistants

Japanese Researchers Claim Detection Of Cancer-Causing Gene
February 5, 2013, RTTNews

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
February 5, 2013,  7th  Space

Could An Asthma Medicine Stop  CML?                      VIDEO
February 4, 2013, Patient  Power

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic  myeloid leukemia: implications for early intervention strategies
February 4, 2013, Blood  Journal

Stem Cell Therapeutics Announces Agreement With Trillium  Therapeutics Inc. for Merger
February 4, 2013, Market  Wire

Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
February 1,   2013, Leukemia

Deaths from  cancer have declined 20% over 20 years
January 31, 2013, Oncology Nurse  Advisor

World cancer day – 2013 – Pat  Garcia-Gonzalez                 VIDEO
January 30 2013, The Max Foundation

Sabutoclax (ONT-701) May BeThe Next Magic Bullet To Combat The Root Of Cancer
January 30 2013,  Science  2.0

FDA Approves Imatinib (Gleevec) for Pediatric ALL
January 30, 2013, Cancer  Network

“I Can’t Afford Any More Advances in Cancer Care, Doc!”
 January 28, 2013, Cancer  Network

Top Blood Cancer Team Joins  NY-Presbyterian/Columbia
January 28, 2013, Newswise

IPO Preview: Stemline Therapeutics
January 28, 2013, Seeking Alpha
 
Targeted cancer treatment case study: 'I'm so grateful that I can  live a normal life'
January 28, 2013, The  Independant

Lanterns carry message of hope for fight against  disease
January 25, 2013, The Independent.com

FDA approves Gleevec for children with acute lymphoblastic  leukemia
January 25, 2013, FDA

Novartis pulls imatinib file in EU for hypertension
January 25, 2013, Pharma Times Online

Pan–BCL-2 Inhibition Sensitizes Leukemic Stem Cells to Kinase Inhibitors
January 24, 2013, Cancer Discovery

ARIAD prices  $300M stock offering to support launch of leukemia  drug
January 24, 2013, Boston Business  Journal

C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal  adhesions in chronic myeloid leukemia cells: implication in the regulation of  leukemic cell adhesion
January 24, 2013, 7th Space

Helping healthy cells could be key to fighting  leukaemia, research suggests
January 23, 2013, Imperial College London

CHMP Positive  on Pfizers Bosutinib
January 23, 2013, Zacks.com

National Academy of Sciences Paper: Dartmouth researchers take  novel approach to fighting treatment-resistant chronic myeloid  leukemia
January 22, 2013, HeathCanal.com
 
Novartis return to growth in 2014,  Vasella replaced by Reinhardt
January 22, 2013, PharmaTimes  Online

Kareem Abdul-Jabbar joins Florida Forum  series
January 22, 2013, Daily  Record

The power of patents
January 22, 2013, Scienceline

10 Predictions That Will Transform Healthcare
January 22, 2013, Genetic Engineering News
 
Advances in treatment for chronic myelogenous leukaemia
January 22, 20131, South China Morning Post

Smart T Cell Vaccines: CAR T Cells - by  Carl June, MD   VIDEO
January 21, 2013, TheOncologistJournal

Flow synthesis for anticancer  drug
January 21, 2013, RSC Advancing the Chemical  Sciences

Pfizer gets CHMP backing for leukaemia drug  bosutinib
Juanuary 21, 2013, PMLIve

Pfizer’s Bosutinib Receives Positive Opinion For Conditional  Marketing Authorization From The Committee For Medicinal Products For Human Use  For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or
Intolerance To Prior Therapy In Europe
January 18, 2013,  Pfizer Press  Releases

Pfizer's Bosulif set for greater sales with EMA  approval
January 18, 2013, Fierce  Pharna

Sanford-Burnham cancer drug targets  hard-to-reach leukemia stem cells
January 18, 2013, Sanford  Burnham

Sabutoclax appears to selectively target  leukemia stem cells that are responsible for  relapses
January 18, 2013, News  Medical

Drug Targets Hard-To-Reach Leukemia Stem Cells Responsible for  Relapses
January 18, 2013, Science Daily

Newly Founded Optum Labs will Analyze Big Data to Improve Patient  are, Lower Costs of Care
January 18, 2013, HealthTechZone.com

Pfizer,  Novartis win EU nods for new leukemia, eye drugs
January 18, 2013, FierceBiotech

Bosutinib in  CML Cleared for Approval in Europe
January 18, 2013,, Medscape

Study: Enzyme  Plays Important Role in CML Stem Cell  Reprogramming
January 18, 2013, Cancer  Network

EMA- CHMP ( Committee  for Medicinal Products for Human Use)recommends the EU Commission grant a
conditional marketing authorisation for 'Bosulif'  (bosutinib)
January 17, 2013, European Medicines Agency

An Expert's Perspective on Changing CML Treatment  Options                  VIDEO
January 17, 2013, Patient Power

Is Stopping CML Treatment a Viable Option  Now?                           VIDEO
January 17, 2013, Patient  Power

Optum and Mayo Clinic look to improve patient care
January 17, 2013, Mas  Device

Drug targets hard-to-reach leukemia stem cells responsible for  relapses
January 17, 2013, Science  Codex

Making Oncology History: Imatinib Pioneer Created His Own  Opportunities
January 17, 2013, Onc LIve

Pat Has Conquered Cancer Twice - Offers Hints for the Rest of  Us
January 16, 2013, About.com

Omacetaxine for Chronic or Accelerated Phase CML Patients with Resistance/Intolerance to Tyrosine Kinase Inhibitors
January 15, 2013, The ASCO Post

India to  issue compulsory licences on  Roche, B-MS drugs
January  15, 2013, PharmaTimet

Early molecular response may predict  outcomes for nilotinib in CML
January 14, 2013,  Healio

Double-unit  cord blood transplants don't boost survival
January 14, 2013, The Oncology  Report

Who should be subsidised?
January 14, 2013, Today  Online

Pharma MNCs upset as govt issues more  compulsory licences - Mandatory licences have been planned for cancer drugs such
as Trastuzumab, Ixabepilone and Dasatinib
January 13, 2013, Business  Standard

Major new clinical trial to  improve treatment for leukaemia  patients
January 12, 2013,  domain-b.com

Two-time Cancer  Survivor's 10 Tips for the Healthcare System
January 12, 2013,  Forbes

Bone Drug Kills Leukemia in Mice
January 11, 2013, BioScienceTechnology

ARIAD and NCRI to collaborate on Phase III chronic myeloid leukemia trial
January 9, 2013, equities.com

Cancer gave us our vows meaning
January 8, 2013, Express.co.uk

ARIAD teams up with UK National Cancer Institute on leukemia  treatment study
January 7, 2013, Boston Business Journal

The spirit of Star Trek
January 7, 2013, MPRnews

ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study
January  7, 2013,  Pharma Live

Journey of CML -    17th Congress of EHA    VIDEO
January 4, 2013, communicationEHA

Patrick signs bill requiring oral cancer drug coverage, over  business groups' opposition
January 4, 2013, Boston Business  Journal

Sorry, but there's no such thing as a  diet that cures cancer
January 1, 2013, Mail  Online

DNA vaccine for leukemia has early positive results
January 1, 2013, Oncology Nurse Advisor

Study Finds  Enzyme Linked to the Acceleration of Malignant Proliferation in CML
January 1, 2013, Doctor  Tipster

A new enzyme that  contributes to the proliferation of leukemia is discovered
December 26, 2012, Private MD News

DNA-repair problems destroy hardy  leukemia cells
December 26, 2012, OncologyNurseAdvisor

Leukemia stem cell trigger discovered by UCSD-led  research
December 24, 2012, UT  San Diego

Latest Treatment and Research for Chronic Myeloid  Leukemia
December 24, 2012, Cancer  Network

Enzyme accelerates malignant stem cell cloning in chronic myeloid  leukemia
December 24, 2012, Eurekalert

A CML Advocate's Perspective on News from ASH  2012                               VIDEO
December 21, 2012, Patient  Power
 
News on CML from the 2012  ASH Conference – our Patients' Perspective
December 21, 2012,  CML Advocates  Network

At the Heart of Genetic Shenanigans
December 21, 2012, DailyRx

Parthenolide eliminates leukemia initiating cell populations and  improves survival in xenografts of childhood acute lymphoblastic
leukemia
December 20, 2012, Blood Journal

Can we safely stop TKI therapies? Experience from the STOP trials                                      VIDEO
Dr. Delphine Rea, Hôpital Saint-Louis,  Paris, France
December 2012, iCMLf

Options increase for CML patients failed by existing drugs
December 21, 2012, EurekAlert

Ponatinib Could Herald “Revolution”in CML Treatment
December 20, 2012, OncLive

Bosutinib a New Option for Chronic Myeloid  Leukemia
December 2012, Clinical  Oncology

New group   CML Life – Africa   on Facebook
December 20, 2012, CMLeukemia
 
New group  CML  Tunisia on  Facebook
December 20, 2012, CMLeukemia

Choosing a Tyrosine Kinase Inhibitor in Chronic Myelogenous Leukemia
December 19, 2012, OncLive

When it comes to  treating his CML, Kareem Abdul-Jabbar shoots and scores
December 18, 2012, JSOnline

Ariad's Wonder Drug For Leukemia  Patients 
December 17, 2012, Seeking Alpha

Drug Approved To Treat Rare Forms Of  Leukemia
December 16, 2012, Medical News Today

New Leukemia Rx Hits  Market
December 14, 2012, dailyRx

OHSU-developed ponatinib wins FDA approval
December 14, 2012, Portland Business Journal

FDA Approves Ponatinib to Treat  Leukemia
December 14, 2012, Cancer  Network

FDA grants approval for potential‘blockbuster’ leukemia drug made
by Cambridge-based Ariad
December 14, 2012, Boston.com

F.D.A. Gives Early Approval to Drug for Rare  Leukemia
December 14, 2012,  The New York  Times

ARIAD Announces Accelerated Approval by FDA of  Iclusig (Ponatinib) for Patients with CML and Ph+ ALL Resistant or Intolerant to  Prior Tyrosine Kinase Inhibitor Therapy
December 14, 2012, Ariad

FDA Approves Ariad Pharma Leukemia Drug
December 14, 2012, The  Street

The prognosis for chronic myeloid leukaemia dramatically improved over time               
December 12, 2012, Doctor Tipster

TKI-resistant human leukemia stem cells are the source of genomic instability
December 12, 2012, News  Medical

Abstracts and notes on CML presentations - ASH 2012 Atlanta 
December 11, 2012, CMLsupport

ASH: Updated PACE Findings Uphold Ponatinib Benefit in CML and  Ph+ ALL
December 11, 2012, Cancer  Network

ASH: Higher Imatinib Exposures  Associated with Better Chronic-Phase CML Outcomes
December 11, 2012, Chemotherapy advisor

Learning about  CML
December 11, 2012, Cure Today

NVS Provides Tasigna Study Data
December 11, 2012, Zacks Equity Research

Ariad reports most patients cancer-free after 1 year in ponatinib study
December 11, 2012, Atlanta Business Journal

Ponatinib Works in  CML When Nothing Else Is Effective
December 11, 2012, Medscape Today

Drug resistant leukemia stem cells may be source of genetic  chaos, Temple scientists find
December 11, 2012, Science Codex

Fatigue Is the Major Aspect Compromising  Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving
Long-Term Imatinib Therapy
December 10, 2012, ASH  2012

Novartis says trial results back Tasigna drug
December 10, 2012, Chicago Tribune

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in  Chronic Myeloid Leukemia
December 10, 2012, ASH2012

Novartis long-term Phase III data show Ph+ CML patients on  Tasigna(R) achieved significantly deeper molecular response versus  Glivec(R)
December 10, 2012, Reuters

A 7-year-old pixie named Emily Whitehead has erased any remaining  doubts about the power of a University of Pennsylvania gene therapy to eradicate  certain blood cancers.
December 10, 2012, philly.com

In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 10, 2012, CBS  Philly

Ariad rises on positive leukemia drug results
December 10, 2012, Boston  Herald.com

In Girl’s Last Hope, Altered Immune Cells Beat  Leukemia
December 9, 2012, The New York Times

Temple scientists target DNA repair to eradicate leukemia stem cells
December 9, 2012,  MedicalXpress

Ariad drug proves effective in curbing chronic leukemia in study
December 9, 2012, Reuters

RAD52-Dependent Synthetic Lethality Eradicates Leukemia Stem  Cells
December 9, 2012, ASH  2012
 
Novel therapeutic agents provide hope for patients with hard-to-treat blood  disorders
December 9, 2012, Science  Codex

ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive  acute lymphoblastic leukaemia
December 9, 2012, ecancernews

Is going for cure in chronic myeloid leukemia possible and  justifiable?
December 8, 2012, Hematology

Studies Assess Role of Genetics, Modified Treatment Strategies to Improve Outcomes and Reduce Toxicity for Patients with Blood  Cancers 
December 8, 2012,  The Sacramento Bee

Winning the Battle Against Leukemia: Positive Early Results in  Clinical Trial for DNA Vaccine
December 7, 2012, Science  Daily

Bristol-Myers Squibb Launches an Online Resource for Patients with Chronic Myeloid Leukaemia in 15 European  Countries
December 7, 2012, equities.com

Inovio Pharmaceuticals Announces  Positive Interim Results in Phase II Leukemia Trial
December 6, 2012, The Sacramento Bee

Ponatinib  offers new hope in drug-resistant leukemia
December 5, 2012 , News-Medical.net
 
What's Hot at ASH This Year?
December 3, 2012, Medscape  Today

Ky. voices: Dr. John D'Orazio says funding for cures is slipping
December 2, 2012, Kentucky.com

Chronic Myeloid Leukemia Mutation Thwarted By Ponatinib
December 2, 2012, Science  2.0
  
Data Published on ARIAD Candidate - Analyst Blog
November 30, 2012, Nasdaq

In CML, Next-Generation TKIs Aim to Boost Outcomes
November 30, 2012, Onc LIve

Ponatinib - New Pill Could Do Wonders for Cancer Patients
November 30, 2012, FM NEWS 101 KXL

Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England  Journal of Medicine

Ponatinib in Refractory Philadelphia  Chromosome–Positive Leukemias
November 29, 2012, The  New England  Journal of Medicine

Ponatinib - Cancer pill targets  previously impenetrable disease-causing gene mutation in leukemia patients
November 29, 2012, OHSU

Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia
November 29, 2012, News Medical

Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal Of Medecine

Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, MD Anderson  News

Attacking Leukemia  Resistance
November 28, 2012, dailyRx

Drug  (Ponatinib) Shows Potential in Leukemia
November 28, 2012, Medpage Today

Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, Science Codex

Ponatinib Acts Against the Most Resistant Types of Chronic Myeloid Leukemia
November 28, 2012,  Science Daily

Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
November 28, 2012, Reuters

Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
November 21, 2012, Journal Blood

BELA: Bosutinib No Better Than Imatinib in Newly Diagnosed CML
November 19, 2012, Cancer Network

OHSU's War on Cancer
November 17, 2012, Portland Monthly

Successful treatment of nilotinib-induced pleural effusion with prednisone.
November 15, 2012, PublMed

Taking care of the caregiver: tips to help yourself and your loved one live with a chronic disease
November 15, 2012, JSOnline

Nilotinib-Resistant CML Cells Show Abnormal Expression of Several Genes, Suggests Therapeutic Targets
November 15, 2012, Cancer Network

Novartis Provides R&D Update - Analyst Blog
November 15, 2012, Nasdaq

ARIAD Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
November 15, 2012, Seeking Alpha

Bio-Path Holdings Successfully Completes Fourth Cohort in Phase I Clinical Trial of Lead Product Can
November 14, 2012, Daily Finance

Leukaemia drug can help treat lymphoma
November 14, 2012, Cambridge News

Can Ariad Survive on 2 Drugs?
November 13, 2012, Motley Fool

Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update
November 13, 2012, HeraldOnline.com ‎

Ariad: A Very Interesting Biotech With An Even More Promising Pipeline
November 13, 2012, Seeking Alpha

Rwanda: Scientists Call for More Research On Leukemia
November 13, 2012, allAfrica.com

Druker speaks on Gleevec, combating leukemia
November 13, 2012, The Daily Barometer

Leukaemia 'wonder drug' could be used to treat range of blood cancers
November 12, 2012, HealthCanal.com

Your Immune System 101: Introduction to Clinical  Immunology                       VIDEO
November 11, 2012, UCtelevision

Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds -Tasigna: "Path to Cure" - a potential paradigm shift in CML treatment
November 9, 2012, PharmaLIve

Will cancer breakthroughs pass economic test?
November 9, 2012, Austin American-Statesman

Joseph Philips Blames Drug Combination for Leukemia
November 9, 2012, Opposing Views

Prospective Histomorphometric and DXA Evaluation of Bone  Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal  Effects.
November 8, 2012, PublMed

Ariad CEO discusses company’s battle against cancer
November 8, 2012, Boston Herald

CML: the good, the better, and the difficult choices
November 8, 2012, Journal Blood

Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds
November 8, 2012, Reuters

Switching Therapy Following Suboptimal Response in Chronic Myelogenous Leukemia
November 7, 2012, OncLive

PropThink: Management says Ariad is Well-Prepared for Ponatinib Launch
November 7, 2012, Reuters

BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, CNBC

BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, Market Watch

How a CML Patient and Doctor Work  Together                    VIDEO
November 6, 2012, Patient  Power

Dandelion root extract human trials approved by Health Canada.  Findings could change cancer treatment
November 5, 2012, The Windsor Star

Doctor still knows best
November 5, 2012,  Chron

Will progress on cancer pass the price test?
November 4, 2012, The Bulletin News

Column: Disabled-sports mentor leader we can get behind
November 2, 2012, azcentral.com

The Partner’s Role During Serious Illness
October 18, 2012, Empower

Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumorsUpcoming ASCO Meeting Could Move These Stocks
April 4, 2012. Seeking Alpha

Piramal to present data on its three IND candidates at AACR annual meeting in Chicago
April 4, 2012, Pharmabiz.com

ARIAD: Xiaotian Zhu on Ponatinib
April 3, 2012, Executive video

Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
April 2, 2012, Business Wire

Clinical Conundrums - quiz for the community hematologist/oncologist
March 2012, Clinical Oncology

Leukemia Drug Fails Mesothelioma Trial
March 31, 2012, Surviving Mesothelioma

Fighting cancer on the home front
March 30, 2012, IrishTimes.com

New inhibitors of a cancer-causing protein may lead to targeted therapeutics
March 29, 2012, Physorg.com

Cancer Research Depends On Clinical Trial Participants
March 29, 2012, 10TV.com

Novartis versus India patent case postponed to July 10
March 29, 2012, Pharma Times

Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients
March 29, 2012, Market Watch

NIH scientists resolve how chromosomal mix-ups lead to tumors
March 28, 2012, PharmPro

Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise

Fighter pilot donates bone marrow
March 28, 2012, The Korea Herald

One in a Million – Children with CML
March 28, 2012, Petaluma Patch

Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter

Relay for Life unites people in the Story County community.
March 24, 2012, Iowa State Daily 

How bodies resist cancer drugs
March 23, 2012, Science Alert

Phase 1 Dose-Escalation Study of  PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic  Malignancies                            VIDEO
March 22, 2012, The Science  Network

"NICE" news for Novartis CML drugs, but not for Bristol-Myers
March 22, 2012, Pharma Letter

It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
March 21, 2012, Asian Scientist 

‘We want a world without blood cancer,’ Bowie survivors say
March 20, 2012, Gazette.net 

For the Treatment of Refractory Chronic Myeloid Leukemia, Interviewed Thought Leaders Indicate That Ponatinib Has Efficacy Advantages over Sprycel, the Sales Leading Agent in the United States
March 19, 2012, Market Watch

Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
March 18, 2012, Science Daily

Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com

The Reactivity of the Cellular Transcriptome to Xenobiotic Compound Perturbation
March 16, 2012, The New York Academy of Sciences

Scientists map genetic evolution of leukemia
March 14, 2012, Medical Xpress

Postal worker saves life of British cancer patient VIDEO
March 15, 2012, msnbc.com

Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs

Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs

Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power

Del Norte students trying to raise $10,000 to fight cancer
March 10, 2012, Pomerado News

Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha

Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX

Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor

Planned Pregnancy  in CML Patient in Molecular Remission
March 6, 2012, Hindawi

Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx

India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times

Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research

I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News

Cancer drugs to help halt Ebola virus
March 2, 2012,PakTibune

Leukemia drugs found effective limiting Ebola
March 1, 2012, The Vancouver Sun

Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
February 2012, Leukemia

Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today

Cancer: Solving an age-old problem
February 29, 2012, Nature

Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today

Cancer drugs could halt Ebola virus
February 29, 2012, MSN News

Blood ambassadors
February 29, 2012, Goulburn Post

Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe

Ten-Year CML Survival Estimate of 68 Percent With Imatinib 
February 28, 2012, OncologyNurseAdvisor

EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients 
February 28, 2012, Pharmabiz.com

Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today

Dr. Erba Describes Proper Diagnostic Testing of CML                        VIDEO
February 27, 2012, Onc Live

Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live

Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 27, 2012, DoctorsLounge

CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net

Novartis' Glivec extends European GIST licence
February 27, 2012,  PMLiVE

Novartis explains stance over India patent law challenge
February 27, 2012,  Pharma Times Online

Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012,  Daily RX

Exploring Disease Risk and Treatment Options for CML                                         VIDEO
February 24, 2012, Patient Power

Dr. Liu makes the case for genomics and personalized medicine
February 24, 2012, The CT mirror

Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online

Montrealer looking for a bone marrow hero Julie Ouimette ​
 -  February 23, 2012, CTV.ca

New heart drug will get government subsidy  
February 21, 2012, The Australian

Hopes high for dandelion root trials in Windsor 
February 20, 2012,  The Windsor Star

Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012,  dailyRx

John Mailes freed from death sentence
February 19, 2012, Herald Sun

New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, Timesunion.com

New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, PRWeb

ELN Recommendations - Patient-friendly summary in seven languages
February 17, 2012, CML Advocates Network

Can dandelions kill cancer?
February 16, 2012, Global Edmonton

Stephens v. Skanska USA Bldg., INC.
February 16, 2012, LEAGLE

Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com

Nilotinib Continues To Produce Deep Response in Patients          
February 2012, Clinical Oncology

Francis Collins: 3 Scientific Breakthroughs Changing Medicine        VIDEO
February 15, 2012, Medscape

Ariad wins key patent for leukemia drug
February 15, 2012,  The Boston Globe

Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape

Bone marrow drive for San Diego firefighter
February 14, 2012, UT San Diego

Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times

Looming shortage of cancer drugs causing concern for many
February 13, 2012, WHPTV.com

Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal

Therapy targets leukemia stem cells
February 13, 2012, Eurekalert

A man's need sparks bone marrow donor drive
February 11, 2011, Fort Dodge Messenger

All You Can Eat Pasta Dinner/Fundraiser for Cancer Charity
February 11, 2012, windsoriteDOTca

In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters

Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx

Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes

Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review

Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica

Local men join NEPA firefighters in charity building climb
February 7, 2012, Thedailyreview.com

Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor

Med schemes can refuse to pay for super drugs
February 5 2012, Personal  Finance

Cyclists to hold 511-km tour for leukemia
February 4, 2012, The Jakarta Post

Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA

Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard

Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live

Penn State: Inspiring Collaboration                          VIDEO
February  2, 2012, Penn State

Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor

Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate

FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN

Phase 1 Clinical Trial of KB004 in  EphA3-Expressing Hematologic  Malignancies
January 2012, Monash  University

2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012, Seeking Alpha

Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE 
January 30, 2012, DailyRx

FDA accepts NDA for Pfizer CML drug
January 30, 2012, Pharmaceutical Business Review‎

Candid Cancer segment - what to know about getting a second opinion.           VIDEO
January 29, 2012,A wider world

Area medical centers provide improvements to cancer treatments
January 28, 2012, greenbaypressgazette.com

CML Update at ASH 2011 - Interview with Elias Jabbour, M.D.       VIDEO
January 27, 2012, OncUViewTV

Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML 
January 26, 2012, Pfizer

For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology

Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg

BB Biotech closes 2011 with a positive performance and confirms upward trend
January 26 ,2012, Reuters

Understanding Molecular Response with Respect to Cure                       VIDEO
January 25, 2012, Patient Power

Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com

Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer

HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood

Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal

Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert

Novartis receives CHMP backing for Glivec label update
January 24, 2012, Zenopa

Chemo Cocktail Produces Better Results
January 24, 2012, DailyRx‎ 

Marathon Against CML Still Not Won
January 24, 2012, DailyRx

EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com

Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitor therapy
January 22, 2012,Heamatologica

Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed

NCMLS  Remembers legendary Etta James
January 21, 2012, NCMLS

Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology

Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011  
January 19, 2011, Business Wire

Analyst: Red-hot Ariad is a possible acquisition target
January 19, 2012, Business journal

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+chronic myeloid leukemia progenitors preserving normal stem cells
January 18, 2012,  Journal Blood

Abdul-Jabbar named State Department cultural ambassador
January 18, 2012, USA Today

Discount wins final NICE OK for Tasigna
January 17, 2012, Pharma Times

Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives
January 15, 2012, PubLMed

Continuing Good News for Chronic Myeloid Leukemia Patients
January 13, 2012, Cancer  Network

Mixed NICE recommendations for CML and diabetes drugs
January 13, 2012,  The Pharma Letter

No longer a bitter pill to swallow (chidren)
January 13, 2012, dailyRx

Cancer drugs should be treated equally
January 12, 2012, The Columbus Dispatch

Ariad: This Bio-Pharma May Deliver Big Returns
January 11, 2012, Seeking Alpha

Kayla Nation: Young Mother with CML Perseveres                                    VIDEO
January 9, 2012, Patient Power

Condolences to the family of Zavie Miller
January 9, 2012, CML World

Sharing News
January 9, 2012, Work in progress

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
January 6, 2012, Journal Blood

Korean Pharmaceutical Company Develops New Leukemia Treatment
January 6, 2012, Arirang

AccuGenomics Seeks to Standardize Gene Expression Tests for Early Leukemia, Lung Cancer Detection
January 4, 2012, OneMedPlace

TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
January 3, 2012, PRNewswire

Afghans’ free treatment: Health dept fears audit objections
January 2, 2012, Dawncom                        

                  See News on CML (after 2020)                  
                                 See Archives ( 2019-2018)
                  See Archives ( 2017-2016)
                  See Archives ( 2015-2014)
                  See Archives ( 2013-2012)
                                 See Archives before 2012